title: Current treatments in neurology: stroke.
abstract: There have been major advances in stroke treatment based on robust evidence from large clinical trials. This review covers both acute treatment and secondary prevention. Thrombolysis is now established as a therapy for ischaemic stroke presenting within 3 hours, and the possibility of extending the time window and refining the selection of suitable patients, is being addressed in further trials. Anticoagulants are of proven benefit in cardioembolic stroke, and particularly atrial fibrillation. For prevention of other stroke subtypes antiplatelet agents appear to have a better risk-benefit ratio. Evidence for the use of dual antiplatelet therapy, including the recent MATCH study, are discussed. Carotid endarterectomy is of proven benefit in patients with>70% symptomatic stenosis. Recent analysis has emphasised the importance of operating as soon after symptom onset as possible. Operating on asymptomatic carotid stenosis remains controversial; even after the recent Asymptomatic Carotid Surgery Trial which showed that by operating on 32 people one disabling stroke or death could be prevented over a 5 years period.
authors.affiliation: Clinical Neuroscience, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. h.markus@sghms.ac.uk
authors.forename: Hugh S
authors.initials: HS
authors.lastname: Markus
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009462:Neurology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009493:Neurosurgery / Q000379:methods; D015607:Stents; D020521:Stroke / Q000473:pathology / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods
chemical_list: D018696:Neuroprotective Agents; D006493:Heparin; D001241:Aspirin
references.citation: Lancet. 2004 Mar 6;363(9411):768-74
references.pmid: 15016487
references.citation: Lancet. 2001 Jun 2;357(9270):1729-37
references.pmid: 11403808
references.citation: Lancet. 1996 Nov 16;348(9038):1329-39
references.pmid: 8918275
references.citation: Cochrane Database Syst Rev. 2002;(1):CD000197
references.pmid: 11869570
references.citation: N Engl J Med. 2000 Jan 20;342(3):145-53
references.pmid: 10639539
references.citation: Lancet. 2004 May 8;363(9420):1491-502
references.pmid: 15135594
references.citation: BMJ. 2004 Feb 28;328(7438):514-7
references.pmid: 14988196
references.citation: Ann Neurol. 1997 Dec;42(6):857-65
references.pmid: 9403477
references.citation: Lancet. 2002 Mar 23;359(9311):995-1003
references.pmid: 11937178
references.citation: N Engl J Med. 2001 Aug 16;345(7):494-502
references.pmid: 11519503
references.citation: Lancet. 1998 May 9;351(9113):1379-87
references.pmid: 9593407
references.citation: N Engl J Med. 1991 Aug 15;325(7):445-53
references.pmid: 1852179
references.citation: Cochrane Database Syst Rev. 2003;(3):CD000213
references.pmid: 12917889
references.citation: Lancet. 2004 Jul 24-30;364(9431):331-7
references.pmid: 15276392
references.citation: JAMA. 2002 Nov 20;288(19):2411-20
references.pmid: 12435254
references.citation: Ann Neurol. 2002 Jul;52(1):20-8
references.pmid: 12112043
references.citation: N Engl J Med. 1998 Nov 12;339(20):1415-25
references.pmid: 9811916
references.citation: JAMA. 2000 Dec 13;284(22):2901-6
references.pmid: 11147987
references.citation: Cerebrovasc Dis. 1999 Jul-Aug;9(4):193-201
references.pmid: 10393405
references.citation: Stroke. 2004 Feb;35(2):363-4
references.pmid: 14757880
references.citation: J Neurol Sci. 1996 Nov;143(1-2):1-13
references.pmid: 8981292
references.citation: JAMA. 1995 May 10;273(18):1421-8
references.pmid: 7723155
references.citation: Acta Neurochir Suppl. 2003;86:441-3
references.pmid: 14753482
references.citation: BMJ. 2000 Feb 26;320(7234):549
references.pmid: 10688561
references.citation: Am J Cardiovasc Drugs. 2003;3(2):87-94
references.pmid: 14727935
references.citation: BMJ. 2002 Jan 12;324(7329):71-86
references.pmid: 11786451
references.citation: N Engl J Med. 2001 Nov 15;345(20):1444-51
references.pmid: 11794192
references.citation: BMJ. 2004 Feb 7;328(7435):326
references.pmid: 14744823
references.citation: Lancet. 1997 May 31;349(9065):1569-81
references.pmid: 9174558
references.citation: Lancet. 1993 Nov 20;342(8882):1255-62
references.pmid: 7901582
references.citation: Lancet. 2004 Feb 7;363(9407):439-45
references.pmid: 14962524
references.citation: Lancet. 2001 Sep 29;358(9287):1033-41
references.pmid: 11589932
references.citation: Lancet. 2004 Mar 20;363(9413):915-24
references.pmid: 15043958
references.citation: BMJ. 2004 Feb 14;328(7436):369
references.pmid: 14962873
references.citation: J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):353-61
references.pmid: 14966145
references.citation: Ann Intern Med. 1999 Oct 5;131(7):492-501
references.pmid: 10507957
references.citation: Lancet. 2003 Jun 14;361(9374):2005-16
references.pmid: 12814710
references.citation: Stroke. 2003 Aug;34(8):e138-40
references.pmid: 12855835
references.citation: Cerebrovasc Dis. 2004;17 Suppl 1:81-8
references.pmid: 14694285
references.citation: Lancet. 1997 Jun 7;349(9066):1641-9
references.pmid: 9186381
references.citation: Stroke. 2004 Feb;35(2):389-91
references.pmid: 14757889